This post has been archived and contains information that may be out of date.
The Department of Health & Human Services (HHS) has announced it will purchase 60,000 doses of the COVID-19 monoclonal antibody treatment bebtelovimab to provide no-cost access for the uninsured and underinsured.
This content is restricted to members.
